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Abstract
Although Nlrp3 inflammasome activation in macrophages has been shown to be critical for the development of
atherosclerosis upon atherogenic stimuli, it remains unknown whether activated Nlrp3 inflammasomes by other non-
atherogenic stimuli induce alterations in macrophages that may contribute in the concert with other factors to
atherogenesis. Thus, the present study tested the hypothesis that activation of Nlrp3 inflammasomes by ATP, which is a
classical non-lipid danger stimulus, enhances the migration of macrophage and increases lipids deposition in macrophages
accelerating foam cell formation. We first demonstrated that extracellular ATP (2.5 mM) markedly increased the formation
and activation of Nlrp3 inflammasomes in bone marrow macrophages (BMMs) from wild type (Asc+/+) mice resulting in
activation of caspase-1 and IL-1b production. In these Asc+/+ macrophages, such stimulation of inflammasomes by non-lipid
ATP was similar to those induced by atherogenic stimuli such as cholesterol crystals or 7-ketocholesterol. Both non-lipid and
lipid forms of stimuli induced formation and activation of Nlrp3 inflammasomes, which were prevented by Asc gene
deletion. Interestingly, Asc+/+ BMMs had dramatic lipids accumulation after stimulation with ATP. Further, we demonstrated
that large amount of cholesterol was accumulated in lysosomes of Asc+/+ BMMs when inflammasomes were activated by
ATP. Such intracellular and lysosomal lipids deposition was not observed in Asc2/2 BMMs and also prevented by caspase-1
inhibitor WEHD. In addition, in vitro and in vivo experiments revealed that migration of Asc+/+ BMMs increased due to
stimulation of Nlrp3 inflammasomes, which was markedly attenuated in Asc2/2 BMMs. Together, these results suggest that
activation of Nlrp3 inflammasomes remarkably increases the susceptibility of macrophages to lipid deposition and their
migration ability. Such novel action of inflammasomes may facilitate entry or retention of macrophages into the arterial
wall, where they form foam cells and ultimately induce atherosclerosis.
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Introduction
The inflammasome is intracellular inflammatory machinery
that has been reported to switch on the inflammatory response of
tissues or organs to various danger signals [1,2]. Among different
types of inflammasomes, the Nod-like receptor family pyrin
domain containing 3 (Nlrp3) inflammasome is well characterized
in a variety of mammalian cells, as a receptor for endogenous
danger signals such as ATP, cholesterol crystals, b-amyloid and
monosodium urate [3,4,5,6,7,8,9]. The Nlrp3 inflammasome
typically forms a complex with the adaptor protein apoptosis-
associated speck-like protein (Asc) and caspase-1. Stimulation with
danger or inflammatory signals triggers Nlrp3 inflammasome
assembly and the formation of a large multi-molecular complex
that controls caspase-1 activity and subsequent bioactive IL-1b
production [4,10,11,12,13].
There is substantial evidence showing that accumulated lipids in
macrophages exist not only in cytoplasmic inclusions as cholesteryl
ester inclusions but also in lipid-swollen lysosomes as both free
cholesterol and cholesteryl ester during atherosclerosis [14,15].
This lipid deposition in the cytosol and lysosomes critically
contributes to the foam cell formation in arterial walls, ultimately
resulting in arterial wall fibrosis or atherosclerosis [16]. It is known
that the foam cells are important to the formation of atheroscle-
rotic plaques and ultimate arterial sclerosis and that vascular
inflammation may initiate such pathological changes in macro-
phages. However, it is unknown whether activation of inflamma-
somes in macrophages even before vascular inflammation also
contributes to atherosclerosis. In particular, it is imperative to
know whether non-lipid danger signals activating the inflamma-
some in macrophages may alter lipid metabolism or transport in
these cells and thereby increase the potential to lead to the
formation of foam cells and sclerosis in arterial walls. This is
particular relevant to the development of atherosclerosis in
patients with chronic inflammation or with chronic or remittent
bacterial or viral infections, where they may have activated
inflammasomes through damage-associated molecular patterns
(DAMPs) or pathogen-associated molecular patterns (PAMPs).
The present study was designed to test the hypothesis that
activation of Nlrp3 inflammasomes even by non-lipid danger
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stimuli such as ATP impairs the ability of macrophages to properly
handle lipid metabolism or transport and enhances their migration
capacity to accelerate foam cell formation and migration to
inflammatory tissues. Our data show a formation and activation of
Nlrp3 inflammasomes in bone marrow derived macrophages
(BMMs) in response to ATP (non-lipid), cholesterol crystal and 7-
ketocholestrol (lipid). ATP-induced activation of Nlrp3 inflamma-
somes caused a deposition of cholesterol in lysosomes in BMMs
and enhanced migration of these cells, events that were abrogated
or attenuated by Asc gene knockout. Our findings support the
view that activation of Nlrp3 inflammasomes in macrophages even
by non-lipid stimuli may alter macrophage’s lipid metabolism and
migration, thereby increasing the susceptibility of foam cell
formation and macrophage infiltration into local inflammatory
tissues. During atherogenesis, such actions of Nlrp3 inflamma-
somes are distinct from typical inflammasome-secreted cytokine
(IL-1b/IL18)-induced inflammatory responses such as T-cell
infiltration in the vasculature, which may implicate an uncanonical
non-inflammatory role of inflammasomes in atherogenesis.
Materials and Methods
Mice
Asc2/2 and wild-type mice (Asc+/+) have been described
previously [6]. Mice were housed in a pathogen free facility. Male
and female mice, 8 weeks of age, were used in all experiments.
Then genotype of Asc2/2 mice was confirmed by RT-PCR and
by the absence of IL-1b release to monosodium urate crystals
(MSU, Invivogen). All protocols were approved by the Institu-
tional Animal Care and Use Committee of the Virginia
Commonwealth University.
Primary culture of bone marrow-derived macrophages
(BMMs)
Bone marrow macrophages (BMMs) were cultured as we
described previously [17]. Briefly, bone marrow cells were
harvested by flushing mouse femurs and tibias with 4 mL BMM
medium: DMEM Gluta MAX with sodium pyruvate medium
supplemented with 10% fetal bovine serum (GIBCO BRL),
10 mM HEPES (Fisher Scientific), 1% NEAA (GIBCO BRL),
100 U of penicillin per ml, 100 mg of streptomycin (BioWhittaker)
per ml, and 15% L-cell supernatant as a source of macrophage
colony-stimulating factor. The cells were passed through a 23G
needle in a 10 ml syringe for 5 times and seeded in T25 plate.
After 4 days in culture, macrophages were supplied with fresh
BMM media, and mature macrophages were used on day 7 of
culture. BMMs were collected by treating cells with 0.25%
trypsin/EDTA. BMMs (56104) were cultured in 1.0 ml fresh
BMM media as described above in a 12-well plate or as indicated.
BMMs were primed with low dose of LPS (1 ng/ml) for 3 h before
any experiments. Cholesterol crystals were prepared as described
previously [8]. ATP and 7-ketocholesterol were purchased from
Sigma and freshly prepared before experiments. IL1b, IL1R
antagonist and IL18 were purchased from Sigma.
Confocal microscopy analysis
For confocal analysis of inflammasome molecules in BMMs,
cultured cells were grown on glass coverslips, stimulated or
unstimulated, fixed in 4% paraformaldehyde in phosphate-buffer
saline (PFA/PBS) for 15 min. After being permeablized with 0.1%
Triton X-100/PBS and rinsed with PBS, the cells were blocked
with 3% donkey serum, and then incubated 1 h at room
temperature with goat anti-Nlrp3 (1:200, Abcam, MA) and rabbit
anti-Asc (1:100, Enzo, PA) or rabbit anti-caspase-1 (1:100, Abcam,
MA). After washing, these slides were probed with primary
antibodies and incubated with Alexa-488- or Alexa-555-labeled
secondary antibodies for 1 h at room temperature. The slides were
mounted and subjected to examinations using a confocal laser
scanning microscope (Fluoview FV1000, Olympus, Japan), with
photos being taken and the colocalization of Nlrp3 with Asc or
caspase-1 analyzed by the Image Pro Plus 6.0 software (Media
Cybernetics, Bethesda, MD, USA). The summarized colocaliza-
tion efficiency data was expressed as Pearson correlation
coefficient (PCC) as we described previously [18].
Western blot analysis
Protein from cell lysate was run on a SDS-PAGE gel,
transferred into PVDF membrane and blocked. Then the
membrane was probed with primary antibodies against active
caspase-1 (1:500 dilution; Santa Cruz Biotech.) overnight at 4uC
followed by incubation with horseradish peroxidase-labeled IgG.
The immunoreactive bands were detected by chemiluminescence
methods and visualized on Kodak Omat film. b-actin (1:500
dilution; Santa Cruz Biotech.) was reprobed to serve as a loading
control. The intensity of the bands was quantified by densitometry
using ImageJ software [19].
IL-1b assay
The cell supernatant of each well (26105 BMMs) in a 12-well
plate was collected to measure the IL-1b production by a mouse
IL-1b ELISA kit (R&D systems, MN) according to the protocol
described by the manufacturer.
FLICA staining of active caspase-1
After stimulation, BMM were labeled with a green fluorescent
probe, FAM-YVAD-fmk caspase-1 FLICATM (Immunochemistry,
Bloomington, IN), which specifically binds the activate form of
caspase-1. Therefore, higher caspase-1 activity will exhibit
increased the percentage of FLICA-positive cells. Flow cytometric
analysis was performed according to the manufacturer’s manual.
In brief, BMMs were incubated with FLICA probes and
propidium iodide (PI) at room temperature for 1 h. After two
washes with PBS, FLICA and PI fluorescence were analyzed by
flow cytometry with a Guava EasyCyte (Guava Technologies,
Hayward, CA). The percentage of FLICA-positive cells was used
to represent relative caspase-1 activity and was normalized to
Asc+/+ control group for comparison.
Lipid deposition in BMM by Oil red O staining
For oil red O staining, the slides with BMMs were proceeded
and stained as described previously [20] with minor modifications.
BMMs (104 cells/well) cultured in 200 ml BMMmedia in chamber
slides were treated as indicated and loaded with oxidized low
density lipoprotein (oxLDL, 10 mg/mL; KALEN Biomedical) for
16 hours. The slides with BMMs were then stained with Oil red O
(0.1% in isopropanol) for lipid accumulation. The Oil red O
staining was examined by light microscopy and images were
obtained by MetaMorph 6.0. The data was represented by the
area percentage of each cell positive for Oil red O stain, which was
calculated in Image Pro Plus 6.0 software. For each sample, at
least 200 cells were analyzed and summarized Oil red O positive
percentages were used for statistical analysis.
Confocal microscopic detection of lysosomal free
cholesterol
To detect free cholesterol in lysosomes, confocal microscopy
was performed to analyze co-staining of filipin (as a marker to stain
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free cholesterol) and Lamp1 antibody (lysosome marker) according
to published methods [21,22]. In brief, after treatment as indicated
and exposure to oxLDL, BMMs in the chamber slides were
stained with filipin (50 mg/ml) and rat anti-mouse Lamp1 (1:500
dilution, BD Biosciences) in PBS containing 1% normal goat
serum. The secondary antibody for Lamp1 was Alexa 555-
conjuated goat anti-rat IgG (1:300 dilution). The slides were
mounted and subjected to examinations using a confocal laser
scanning microscope (Fluoview FV1000, Olympus, Japan). The
purple color spots in the merged image represent the deposited
free cholesterol in lysosomes. The colocalization of colocalization
efficiency data were analyzed by the Image Pro Plus 6.0 software
(Media Cybernetics, Bethesda, MD, USA) and expressed as
Pearson correlation coefficient (PCC) as we described previously
[18]. For each sample, at least 200 cells were analyzed and
summarized PCC data were used for statistical analysis.
Assay of lysosomal cholesterol and ganglioside GM1
The lysosomes of mouse BMMs cultured in a 12-well plate were
isolated by a lysosome isolation kit (LYSISO1, Sigma) with
differential centrifugation, followed by a density gradient centri-
fugation and Ca2+ precipitation following the manufacturer’s
manual as we described previously [23]. The cholesterol
concentrations in lysosomes were determined using a standard
fluorescence assay kit (EnzyChrom AF Cholesterol Assay Kit) as
described previously [24,25]. Cholesterol is oxidized to yield
hydrogen peroxide in a reaction catalyzed by cholesterol oxidase.
In the presence of horseradish peroxidase, hydrogen peroxide is
able to oxidize non-fluorescent 10-acetyl-3, 7-dihydroxyphenox-
azine into highly fluorescent resorufin. The fluorescent intensity
was determined at excitation/emission of 485/530 nm using a
fluorescent microplate reader (FLx800, BIO-TEK Instruments)
and used to calculate cholesterol concentrations following the
manufacturer’s instruction. The lysosomal ganglioside GM1 was
determined by dot blot analysis as described previously [26]. The
lysosomes from 106 BMMs were isolated as described above and
resuspended in 1 ml methanol. PVDF membrane was rinsed with
methanol and dried in air. Then 2 ml of lysosomes in methanol
were loaded on PVDF membrane. The membrane was then
washed in PBS twice and incubated with a specific ganglioside
GM1 binding agent, cholera toxin subunit B conjugated HRP
(Invitrogen, 1:10000), for 30 min. The ganglioside GM1 dots were
detected by chemiluminescence methods and visualized on Kodak
Omat film. The intensity of the bands was quantified by
densitometry using ImageJ software.
Confocal microscopic analysis of BODIPY-LacCer delivery
to lysosomes
To show whether Nlrp3 inflammasome activation alters lipid
transport in BMMs, the intracellular lipid trafficking was
determined using BSA-conjugated BODIPY FL-C5-lactosylcer-
amide (LacCer) and monitoring its endocytic trafficking as
described previously [23,27]. BMMs cultured in chamber slides
were stimulated as indicated and then loaded with LacCer on ice
for 15-min. To visualize the lysosomes, the cells were also labeled
with 1 mM LysoTracker. After a wash with PBS, the PM bounded
LacCer was back exchanged with ice-cold DMEM containing 5%
fatty acid-free BSA at 4uC (3615 min). Then BMMs were
incubated at 37uC for a 30-min chase phase. At the end of chase
point, the cells were subjected to examinations using a confocal
laser scanning microscope (Fluoview FV1000, Olympus, Japan).
The yellow spots in the merged image represent the delivery of
LacCer from endosomes to lysosomes. The data was represented
by the percentage of yellow spots in red spots analyzed in mage
Pro Plus.
Nucleofection of GFP plasmids
Transfection of plasmids encoding GFP (Lonza) into BMMs was
performed using a 4D Nucleofector X-Unit (Lonza) according to
the manufacturer’s instructions as we described recently [28].
Briefly, BMMs were trypsinized and centrifuged at 906 g for 10
minutes. The cell pellet (26106 cells) was re-suspended in 100 mL
P2 Nucleofection solution (Lonza) for Nucleofection with the
program code DL100. For each Nucleofection sample, 2 mg GFP
encoding plasmid DNA was added in 100 mL P2 Nucleofection
solution. After Nucleofection, BMMs were cultured in the BMM
media for 24 h and then used for the in vivo migration assay. The
BMM viability post Nucleofection was determined by PI staining
(0.5 mg/ml) using flow cytometric analysis (Guava Technologies,
Hayward, CA).
In vitro and in vivo migration assay
Migration of mouse BMMs was measured in vitro in a modified
Boyden chamber migration assay using Transwell inserts with a
5 mm porous membrane (Corning) as described previously [29].
The BMMs (1.06104) were loaded into upper chamber of a 96-
well transwell insert (Corning Inc.) with various treatments in the
medium of the same upper chamber. Medium containing 10 ng/
ml MCP-1 was placed in the lower chamber in some studies as
positive control. After 24 h, the inserts were removed and
the migratory BMMs in the lower chamber were counted. In
vivo mouse macrophage migration was determined using a
peritonitis model as described previously [30]. Briefly, GFP-
expressing Asc+/+ or Asc2/2 BMMs were obtained by transfecting
BMMs with GFP plasmids using high efficient Nucleofection
technology as described above. Then, Asc+/+ mice were anesthe-
tized with isoflurane and intravenously injected with GFP-
expressing Asc+/+ or Asc2/2 BMMs (105 cells per mouse).
Migration of macrophages into peritoneal cavity was induced by
injection of 1 ml of zymosan A (1 mg/ml) into the peritoneum.
After 2 h, the mice were killed and the peritoneal lavages were
rapidly collected for enumeration of leukocytes. The macrophages
in the lavage fluids were detected by flow cytometry using APC-
conjugated anti–F4/80 antibody, a macrophage marker (A&D
Serotec Inc.). The exogenous GFP-expressing Asc+/+ or Asc2/2
BMMs were counted by analyzing cells that were double positive
for GFP and APC-F4/80.
Statistics
Data are presented as means 6 SE. Significant differences
between and within multiple groups were examined using
ANOVA for repeated measures, followed by Bonferroni’s multiple
comparison tests. The Students t test was used to detect significant
differences between two groups. P,0.05 was considered statisti-
cally significant.
Results
Induction of Nlrp3 inflammasome formation and
activation by non-atherogenic or atherogenic stimuli in
BMMs
First, we examined the effects of non-atherogenic stimulus (ATP
0-7.5 mM) on the formation of Nlrp3 inflammasomes in cultured
mouse BMMs. To this end, we determined whether Nlrp3, Asc
and caspase-1 co-localize in the cells and form a complex after
treatment with ATP. The confocal microscopy results (Fig. 1A)
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reveal a clear co-localization of Nlrp3 with Asc or Nlrp3 with
caspase-1 upon ATP stimulation for 16 h in a dose-dependent
manner, while almost no co-localization could be detected in
untreated cells. This data indicates the aggregation and assembly
of these inflammasome molecules after ATP-treatment. The
Pearson correlation coefficient (PCC) represents co-localization
efficiency of Nlrp3 with Asc or Nlrp3 with caspase-1 is also
summarized. Significant increases in PCC occurred even at an
ATP concentration of 2.5 mM. The co-localization of Nlrp3 with
other inflammasome molecules after ATP-treatment suggests
increased formation of Nlrp3 inflammasome in BMMs. ATP at
higher concentration (5 and 7.5 mM) induced morphologic signs
of cyotoxicity in BMMs. Thus, an ATP concentration of 2.5 mM
was chosen for the rest of the experiments in the present study. In
additional experiments, we also detected similar increases in Nlrp3
inflammasomes and colocalization pattern upon treatment of
BMMs with atherogenic stimuli cholesterol crystals (CHC, 0-
1 mg/ml) and 7-ketocholesterol (7-Ket, 0–20 mg/ml) (Fig.1B and
1C). We found that cholesterol crystals (0.5 mg/ml) and 7-
ketocholesterol (10 mg/ml) optimally induced formation of Nlrp3
inflammasomes in BMMs with minimum cytotoxicity.
We further demonstrated that Asc gene deletion prevented the
formation and activation of Nlrp3 inflammasomes induced by
optimal dose of ATP (2.5 mM), cholesterol crystals (0.5 mg/ml)
or 7-ketocholesterol (10 mg/ml) in BMMs (Fig.2A–D). In addition,
ATP, cholesterol crystal or 7-ketocholesterol significantly
increased the production of inflammasome product IL-1b in
Asc+/+ BMMs, however, such increases were abolished in Asc2/2
BMMs (Fig.3A–C).
Asc is essential for ATP-induced caspase-1 activation in
BMMs
To further confirm that whether ATP induced caspase-1
activation following inflammasome assembly, we measured the
cleavage of pro-caspase-1 into active caspase-1 by Western blot
analysis and analyzed caspase-1 activity using specific FLICA
probes by flow cytometry. As shown in Fig. 4A, ATP at 2.5 mM
significantly increased the formation of active caspase-1 (20 kDa),
the cleaved fraction from pro-capaspase-1. Consistently, ATP
(2.5 mM)-induced increases in caspase-1 activity were substantially
attenuated in Asc2/2 BMMs compared to those in Asc+/+ BMMs
(Fig.4B).
Activation of Nlrp3 inflammasomes increases lipid
accumulation in BMMs
Next, we examined whether activated Nlrp3 inflammasomes by
other non-atherogenic stimuli induce alterations in macrophages
that may contribute in the concert with other factors to
atherogenesis. High concentration of intercellular ATP was
generally considered as a danger signal; however, ATP alone is
non-atherogenic. Thus, we examined whether the activation of the
inflammasome by non-atherogenic stimulus ATP may result in
dysregulation of lipid metabolism and deposition in BMMs, a
change that occurs early in macrophages involved in the
development of atherosclerosis. As shown in Figure 5A and
summarized data in Figure 5B, ATP significantly increased lipid
loading in BMMs as detected by Oil Red O staining. The caspase-
1 inhibitor Z-WEHD-FMK (WEHD), IL1R antagonist (IL1Ra) or
Asc gene deletion blocked the lipid loading of BMMs by ATP.
Similarly, another non-lipid inflammasome stimulus MSU also
enhanced lipid deposition which was blocked by WEHD.
Moreover, administration of Nlrp3 inflammasome product, IL-
1b but not IL18, produced more dramatic increase in lipid
accumulation, which was not blocked by WEHD or Asc gene
deletion. These results suggest that inflammasome activation in
macrophages stimulated by non-atherogenic stimuli such as ATP
also increases their lipid loading potential and sensitivity to form
foam cells.
Asc gene deletion and capase-1 inhibition block
inflammasome-induced cholesterol deposition in
lysosomes of BMMs
To gain insight into the composition of the lipids deposited in
macrophages, we performed cholesterol staining with filipin. As
shown in Fig. 6A and 6B, intense and widespread filipin staining
(purple color) was found in BMMs stimulated by ATP indicating
accumulation of cholesterol in the lysosomes of these cells. ATP-
induced cholesterol deposition in lysosomes was blocked by
WEHD and it was absent in Asc2/2 BMMs (Fig. 6A and 6B).
Vice versa, IL-1b induced lysosomal deposition of cholesterol in
both Asc+/+ and Asc2/2 BMMs (Fig.6A and 6B). Further evidence
for the role of inflammasome in lipid accumulation in the
lysosomes was obtained by measuring cholesterol in isolated
lysosomes. These studies confirmed the filipin stainings and show
that ATP increased lysosomal cholesterol concentration, which
was markedly attenuated by WEHD or Asc gene deletion, while
increased by IL-1b (Fig.6C). Further, ATP-induced increases in
lysosomal cholesterol level was blocked by IL1R antagonist and
IL18 had no effect on lysosomal cholesterol level. These results
again confirm that non-atherogenic stimulation-induced Nlrp3
inflammasome activation and its product IL-1b impair the ability
of macrophages for clearance of cholesterol in lysosomes.
Activation of inflammasome impairs intracellular lipid
trafficking
To study the role of inflammasome in lipid trafficking in living
cells, we loaded BMMs with BODIPY FL-C5-LacCer and
observed its intracellular trafficking using confocal microscopy.
After endocytosis into vesicles, this fluorescent ceramide analog is
trafficked to intracellular organelles such as Golgi apparatus or
lysosomes. Non-atherogenic stimulation of BMMs by ATP
significantly increased the overlap (yellow punctuated staining)
between LacCer (red) and LysoTracker (green) indicating that
LacCer probes were accumulated in the lysosomes (Fig. 7A and
7B). Such accumulation of LacCer in lysosomes was substantially
attenuated by WEHD or Asc gene deletion (Fig. 7A and 7B). To
examine whether ATP results in lysosomal accumulation of
sphingolipids, we directly measured the lysosomal content of a
typical glycosphingolipid ganglioside GM1 in BMMs. As shown in
Fig.7C and 7D, ATP markedly increased ganglioside GM1
contents in lysosomes, which was attenuated by ASC gene deletion
or caspase-1 inhibitor WEHD.
Enhanced macrophage migration by activation of
inflammasomes is independent of IL-1b
We next examined macrophage migration in vitro in a Boyden
chamber assay using Transwell inserts with a 5 mm porous
membrane. Cells that migrated on the lower side of the insert
membrane were quantified. Enhanced migration was observed in
Asc+/+ BMMs when they were incubated with non-atherogenic
ATP (Fig. 8), which was attenuated in Asc2/2 BMMs. However,
macrophage migration induced by such non-atherogenic stimula-
tion was not blocked by either WEHD or IL1R antagonist.
Similarly, MSU markedly increased migration of BMMs which
was attenuated by Asc gene deletion but was not affected by
WEHD. Further, ATP-induced migration of BMMs was not
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mimicked by either IL-1b or IL18. These results suggest that
macrophage migration enhanced by Nlrp3 inflammasome activa-
tion is independent of IL-1b and IL18.
Asc gene deletion inhibits macrophage migration in vivo
To evaluate the effect of Asc gene deletion on macrophage
migration in vivo, we measured Zymosan A-induced recruitment of
macrophages into peritoneal cavity using a murine peritonitis
model and GFP-expressing BMMs. To obtain GFP-expressing
BMMs, we used traditional liposome method to transfect BMMs
with GFP cDNA plasmids. However, the transfection efficiency
was very low (,2%) (data not shown), which may be due to hard-
to-transfect nature of primary cells including BMMs. To obtain
high transfection efficiency as well as cell viability, the present
study introduced GFP gene into Asc+/+ and Asc2/2 BMMs by a
novel Nucleofection technology that directly delivers GFP cDNA
plasmids into nucleus ensuring GFP expression. Indeed, as shown
in Fig.9A, Nucleofection method had little effects on cell viability
for both Asc+/+ and Asc2/2 BMMs (PI2 cells .95%) but
markedly increased the transfection efficiency as shown by
increased GFP+PI2 BMM population (GFP+PI2 cells were
quantified as live BMMs expressing GFP) in both Asc+/+ BMMs
(41% of total cells were GFP+PI2 cells) and Asc2/2 BMMs (37%
of total cells were GFP+PI2 cells). For in vivo migration assay, we
intravenously injected these GFP-expressing Asc+/+ or Asc2/2
BMMs into Asc+/+ mice (i.v. 105 GFP expressing BMMs per
mouse). Then, 2 h after intraperitoneal injection of Zymosan A,
we isolated the peritoneal lavage fluids, collected peritoneal cells
and analyzed these cells by flow cytometry as described in the
Methods. As shown in Fig. 9B, when Asc+/+ mice were
Figure 1. ATP, cholesterol crystal or 7-ketocholesterol increased inflammasome formation in Asc+/+ BMMs. (A) Representative confocal
fluorescence images and summarized data depicting the effect of ATP (0–7.5 mM, 16 h) on the colocalization between Nlrp3 and Asc or caspase-1 in
Asc+/+ BMMs. (B) Representative confocal fluorescence images and summarized data depicting the effect of cholesterol crystal (0–1 mg/ml, 16 h) on
the colocalization between Nlrp3 and Asc or caspase-1 in Asc+/+ BMMs. (C) Representative confocal fluorescence images and summarized data
depicting the effect of 7-ketocholesterol (0–20 mg/ml, 16 h) on the colocalization between Nlrp3 and Asc or caspase-1 in Asc+/+ BMMs. * P,0.05 vs.
untreated control group (n = 6).
doi:10.1371/journal.pone.0087552.g001
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intravenously injected with 105 GFP-expressing Asc+/+ BMMs,
approximately 56103 of these GFP-expressing cells were detected
in the peritoneal fluid of each mouse after Zymosan A injection. In
contrast, when Asc+/+ mice were injected with 105 GFP-expressing
Asc2/2 BMMs, much less GFP-expressing Asc2/2 BMMs (,500
cells) were detected in the peritoneal lavage fluids after mice were
injected with Zymosan A. Thus, these data suggest that Asc is
needed for macrophage migration in vivo.
Discussion
The present study demonstrated that formation and activation
of Nlrp3 inflammasomes induced by the non-atherogenic danger
Figure 2. Effects of ATP, cholesterol crystals and 7-Ketocho-
lesterol on Nlrp3 inflammasome formation in Asc+/+ and Asc2/2
BMMs. (A) Representative confocal fluorescence images depicting the
effects of cholesterol crystals (CHC, 0.5 mg/ml, 16 h), 7-ketocholesterol
(7-Ket, 10 mg/ml, 16 h), or ATP (2.5 mM, 16 h) on the colocalization
between Nlrp3 and Asc from Asc+/+ and Asc2/2 BMMs. (B) Summarized
data showing colocalization efficiency between Nlrp3 and Asc. (C)
Representative confocal fluorescence images depicting the effects of
cholesterol crystals (CHC, 0.5 mg/ml, 16 h), 7-ketocholesterol (7-Ket,
10 mg/ml, 16 h), or ATP (2.5 mM, 16 h) on the colocalization between
Nlrp3 and caspase-1 from Asc+/+ and Asc2/2 BMMs. (D) Summarized
data showing colocalization efficiency between Nlrp3 and caspase-1.
* P,0.05 vs. untreated Asc+/+ control group;# P,0.05 Asc2/2 vs. Asc+/+
group (n = 6).
doi:10.1371/journal.pone.0087552.g002
Figure 3. Effects of ATP, cholesterol crystals and 7-Ketocho-
lesterol on IL-1b production in Asc+/+ and Asc2/2 BMMs. BMMs
were stimulated with ATP (0–7.5 mM) (A), cholesterol crystals (CHC, 0–
1 mg/ml) (B) or 7-ketocholesterol (7-Ket, 0–20 mg/ml) (C) for 16 h and
IL-1b concentrations in the supernatants were determined by ELISA.
* P,0.05 vs. untreated Asc+/+ control group;# P,0.05 Asc2/2 vs. Asc+/+
group (n = 6).
doi:10.1371/journal.pone.0087552.g003
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signal ATP was associated with increased lipid deposition in
lysosomes and enhanced migration ability in macrophages. In
contrast, Asc gene deletion markedly abolished Nlrp3 inflamma-
some activation, attenuated lysosomal lipid deposition and
decreased macrophage migration ability. These results suggest
that the formation and activation of Nlrp3 inflammasomes by non-
atherogenic stimulation alters macrophage function and increase
the susceptibility of these cells to formation of foam cells.
Recent studies have suggested that atherogenesis can be
initiated by endogenous molecules mediating sterile inflammation.
One such molecule is crystalline cholesterol, as engulfment of
cholesterol crystals by macrophages leads to the activation and
recruitment of inflammatory cells, endothelial dysfunction and
plaque formation. Nlrp3 acts as the sensory component to
recognize these endogenous danger signals [9,31,32], when Asc
and caspase-1 are recruited to form a protein complex, where
caspase-1 is activated. The present study aimed to explore whether
Nlrp3 inflammasome activation by non-atherogenic stimuli
contributes to the initial steps of atherogenesis by altering
macrophage function. By confocal microscopic and biochemical
analyses, we demonstrated that in macrophages, Asc is essential for
Nlrp3 inflammasome formation and activation induced by the
prototype, non-atherogenic stimulus ATP as well as by typical
atherogenic stimulus 7-ketocholesterol and a recently identified
atherogenic stimulus cholesterol crystal. The present study was
designed to examine whether activation of inflammasomes may
also cause macrophage dysfunction in addition to turning on the
classical inflammatory responses. In this regard, we next demon-
strated that Nlrp3-mediated inflammasome activation caused
macrophage dysfunction including increased lipid deposition and
enhanced migration. Our results support the view that Nlrp3
inflammasome activation not only instigates inflammatory re-
sponse, but also has direct effects to alter cell functions leading to
cell injury.
The present study provides the first evidence that Nlrp3
inflammasome activation increased cholesterol deposition in
lysosomes of macrophages exposed to oxLDL. Asc gene deletion
and caspase-1 inhibition by WEHD blocked ATP-induced
abnormal lysosomal cholesterol deposition in these macrophages.
Moreover, IL-1b alone strongly increased lipid deposition and
lysosomal cholesterol accumulation implicating the role of caspase-
1/IL1b in mediating such action of an inflammasome in
macrophages. This result is consistent with previous studies
showing that IL1b is involved in a variety of cellular activities,
including cell proliferation, differentiation, and apoptosis in
addition to function as an important mediator of the inflammatory
response [1,28,33]. Taken together, our data suggest that Nlrp3
inflammasome activation facilitates transformation of macrophag-
es into lipid-laden foam cells, which reveals a novel role of the
Nlrp3 inflammasome in regulating macrophage function. Athero-
sclerosis is a disease characterized by accumulation of lipids and an
inflammatory response in the arterial intima, resulting in the
formation of plaque that can lead to arterial narrowing and that is
susceptible to rupture with acute thrombotic occlusion. In the
initial stage of atherogenic inflammation, monocyte-derived
macrophages perform a critical role by internalizing oxLDL
through scavenger receptors and emigrating from the inflamma-
tory site after clearing the lipids [34,35]. The release of high
concentrations of ATP in the arterial wall associates with necrosis,
which occurs only in advanced lesions. It should be noted that the
present study used ATP as a prototype non-lipid inflammasome
stimulus. By using another inflammasome stimulus MSU, we
demonstrated that lipid deposition is associated with inflamma-
some activation rather than the forms of inflammasome stimuli.
Thus, it is plausible that in vivo activation of the Nlrp3
inflammasome activation by non-lipid danger factors other than
ATP increases macrophage transformation into lipid-laden foam
cells, which remain in the lesion after clearing the lipids. Increased
numbers of macrophages trapped in the arterial intima may
provoke an inflammatory response at the local site, ultimately
contributing to the initiation and development of atherosclerosis.
Our data suggest that abnormal lipid deposition and lysosomal
cholesterol accumulation are due to impaired intracellular lipid
trafficking in macrophages upon Nlrp3 inflammasome activation
by non-atherogenic stimulus ATP. The relationship between
cholesterol and glycosphingolipid homeostasis is complex. Previ-
ous studies have shown that cholesterol and glycosphingolipids
have high affinity for one another and are the two main
components of lipid raft microdomains, and therefore accumula-
tion of these sphingolipids in lysosomes can cause lysosomal
trapping and accumulation of the cholesterol [36]. In the present
study, we found that inflammasome activation by ATP increased
lysosomal LacCer accumulation in macrophages in the absence of
cholesterol loading (i.e. these BMMs were not treated with oxLDL)
(Fig.7A and 7B). These data suggest that inflammasome activation
may impair the post-lysosomal trafficking of LacCer to the Golgi
apparatus resulting in accumulation of LacCer in lysosomes.
Figure 4. Asc gene knockout inhibited ATP-induced caspase-1
activation in BMMs. (A) Western blot analysis showing the effect of
ATP (2.5 mM, 16 h) on active caspase-1 expression and the quantitative
analysis (lower blot). (B) Summarized data of FLICA assays quantifying
the relative caspase-1 activity compared to control. * P,0.05 vs.
untreated Asc+/+ control group; # P,0.05 vs. Asc+/+ ATP group (n = 6).
doi:10.1371/journal.pone.0087552.g004
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Consistently, ATP markedly increased lysosomal contents of
glycosphingolipid such as ganglioside GM1, which were attenu-
ated by ASC gene deletion or caspase-1 inhibitor WEHD
(Fig.7C and 7D). Thus, our results support the view that Nlrp3
inflammasome activation impairs post-lysosomal trafficking of
glycosphingolipids to the Golgi, resulting in lysosomal accumula-
tion of these sphingolipids, which may lead to retention of
cholesterol in the lysosomes.
In addition to modulate lipid trafficking and deposition in
macrophages, our in vitro and in vivo data also reveal that
inflammasome activation may increase macrophage migration
ability. The data from our in vitro study show attenuated migration
activity of Asc2/2 macrophages compared to Asc+/+ macrophages
upon stimulation with non-atherogenic ATP. However, such
increases in macrophage migration ability were not blocked by
WEHD or mimicked by IL-1b. Thus, the mechanisms by which
activated Nlrp3 inflammasomes enhance macrophage lipid
deposition and migration may be different. It should be noticed
that Asc deficiency only partially attenuated macrophage migra-
tion ability induced by ATP in our in vitro migration assays, which
may be due to activation of Asc-independent mechanism by ATP
that enhances macrophage migration ability. Previous studies have
shown that P2Y2, a P2Y-family purinergic G-protein coupled
receptor can be activated to induce THP-1 monocyte migration
even at low ATP concentration (100 nM) [37]. In the present
study, the BMMs was treated high ATP concentration (2.5 mM)
which has been well documented to activate P2X7 receptor
leading to Nlrp3/Asc/caspase-1 inflammasome complex forma-
tion. Thus, our data support the view that ATP has dual effects on
macrophage migration ability. First, ATP initiates P2X7-mediated
Nlrp3/Asc/caspase-1 signaling that regulates macrophage migra-
tion ability. In addition, ATP at high concentration may also
activate inflammasome-independent P2Y2 receptor-mediated
chemotactic responses of monocytes/macrophages.
Our findings from animal experiments further confirmed the
non-inflammatory role of Asc in macrophage migration in vivo.
The in vivo macrophage peritoneal influx model used in these
studies is an appropriate system to probe the non-inflammatory
effects of Asc gene deletion on macrophage migration to the
inflammatory lesions. In this system, only wild-type mice were
used for peritonitis model and all mice were injected with same
number of GFP-expressing Asc+/+ or Asc2/2 BMMs in the
circulation. Thus, the Zymosan A-induced inflammatory respons-
es (such as chemokine production) in host mice receiving either
GFP-expressing Asc+/+ or Asc2/2 BMMs are similar and the
factors influencing monocyte recruitment are eliminated. To this
respect, the difference of migration ability between injected Asc+/+
or Asc2/2 BMMs would be attributed to Asc-dependent non-
inflammatory mechanisms in these cells. Indeed, abrogation of Asc
gene markedly blocked migration ability of macrophages in our in
vivo animal experiments. In the in vivo model, Nlrp3 inflammasome
and Asc-dependent migration of macrophages can be activated by
multiple mechanisms such as reactive oxygen species (ROS) or
lysosome destabilization-cathepsin B cascade in addition to ATP/
Figure 5. Increased lipid accumulation in BMMs with activation of Nlrp3 inflammasomes by ATP. BMMs were primed with LPS (1 ng/ml)
for 3 h and treated with ATP (2.5 mM, 16 h), IL1b (0.5 ng/ml), MSU (100 mg/ml), or IL18 (25 nM). Some group of BMMs were treated with ATP or MSU
in the presence of caspase-1 inhibitor WEHD (0.15 mg/ml) or IL1R antagonist (IL1Ra, 40 ng/ml). Then, BMMs were loaded with oxLDL (10 mg/mL) for
16 hours. (A) Light microscopic images show oil red O stained BMMs. Cells were counterstatined with hematoxylin. (B) Summarized data showing
area percentage of each cell positive for Oil red O staining in BMMs. * P,0.05 vs. untreated Asc+/+ control group; # P,0.05 vs. Asc+/+ ATP group; $
P,0.05 vs. Asc+/+ MSU group (n = 6).
doi:10.1371/journal.pone.0087552.g005
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P2X7 signaling [38]. This may explain that the reduction of
migration in Asc2/2 BMMs was more pronounced in in vivo model
compared with that in in vitro assays using ATP. The mechanism
for Asc inflammasome-dependent migration in macrophages is
unknown. Recent studies suggest that Asc may play a role in
regulating macrophage migration ability via Rac signaling
pathway [39]. Asc controls mRNA stability and expression of
DOCK2, a guanine nucleotide exchange factor that mediates
Figure 6. Asc gene deletion and caspase-1 inhibition blocked
cholesterol deposition in lysosomes. BMMs were primed with LPS
(1 ng/ml) for 3 h and treated with ATP (2.5 mM, 16 h) in the absence or
presence of caspase-1 inhibitor WEHD (0.15 mg/ml), or IL1b (0.5 ng/ml)
alone. Then BMMs were loaded with oxLDL (10 mg/mL) for 16 hours. (A)
Representative confocal fluorescent images showing the colocalization
between filipin (cholesterol) and Lamp1 (lysosome marker). An increase
in the purple color in overlay images indicates increased cholesterol
trapping in lysosomes. (B) Quantified and summarized data showing co-
localization co-efficiency between filipin and Lamp1. (C) Effect of Asc
gene deletion on cholesterol level in isolated lysosomes from BMMs.
Lysosomes were isolated from Asc+/+ and Asc2/2 BMMs and cholesterol
concentration in these isolated lysosomes were determined using a
standard fluorescence assay kit. Some groups of cells were pretreated
with ATP in the presence of IL1R antagonist (IL1Ra, 40 ng/ml) or IL18
(25 nM) alone. * P,0.05 vs. untreated Asc+/+ control group; # P,0.05
vs. Asc+/+ ATP group (n = 6).
doi:10.1371/journal.pone.0087552.g006
Figure 7. ATP-induced lipid trafficking in lysosomes was
blocked in Asc2/2 BMMs. Asc+/+ and Asc2/2 BMMs were primed
with low dose of LPS (1 ng/ml) for 3 h and treated with ATP (2.5 mM,
16 h) in the absence or presence of caspase-1 inhibitor WEHD (0.15 mg/
ml). (A) BMMs were incubated with BSA-conjugated BODIPY FL-C5-
lactosylceramide (LacCer) and lipid trafficking was tested by following
LacCer trafficking. Representative confocal fluorescent images show the
co-localization between LacCer (red color) and Lysotracker (green
color). An increase in the yellow color in overlay images indicates
increased LacCer trafficking to the lysosomes. (B) Quantified and
summarized data showing the percent of lipid in lysosomes. (C) The
ganglioside GM1 levels in isolated lysosomes from BMMs were
determined by dot blot analysis. Represent dot blot image shows the
ganglioside GM1 level in isolate lysosome homogenates as detected by
cholera toxin-conjugated HRP. (D) Summarized analysis of ganglioside
GM1 in lysosomes. * P,0.05 vs. untreated Asc+/+ control group; #
P,0.05 vs. Asc+/+ ATP group (n = 6).
doi:10.1371/journal.pone.0087552.g007
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Rac-dependent signaling in immune cells and Asc deficiency
results in impaired Rac-mediated actin polymerization leading to
defective lymphocyte migration in Asc2/2 mice [39]. It is possible
that activation of Asc-associated inflammasome in macrophages
plays a similar role in regulating macrophage migration ability.
In summary, the present study revealed that activation of
inflammasomes even induced by non-lipid stimuli may lead to
abnormal lipid metabolism in macrophages and thereby increases
the potential to accumulate cholesterol in lysosomes as well as
regulates migration of macrophages. These non-inflammatory
effects of inflammasomes on macrophages may ultimately result in
formation of foam cells promoting atherosclerosis.
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